BlackRock reports no Exxon Mobil stake for its reporting units in amended 13G
BlackRock, Inc. reported beneficial ownership of zero shares of Exxon Mobil common stock as of Sept. 30, according to an amended Schedule 13G filed Tuesday.
The filing lists BlackRock's stake at 0.0% of Exxon's common stock, with no sole or shared voting power and no sole or shared power to dispose of shares. BlackRock also marked the item on the form used to report that a holder owns 5% or less of the class.
The zero figure has a defined scope. The filing says it reflects shares beneficially owned by certain BlackRock business units, which it calls the "Reporting Business Units," and does not include shares, if any, held by other BlackRock units whose ownership is disaggregated from theirs under a January 1998 SEC release.
The amendment does not give share counts for those other units, and it does not describe any purchases or sales during the period.
What BlackRock certified
BlackRock filed under Rule 13d-1(b) and identified itself as a parent holding company. It certified that the securities covered by the filing "were acquired and are held in the ordinary course of business" and not for the purpose of changing or influencing control of Exxon, according to the 13G/A.
The filing also states that various persons have the right to receive dividends from, or the proceeds from the sale of, Exxon common stock, and that no one person's interest is more than 5% of the total outstanding shares.
The document is Amendment No. 15 to BlackRock's Schedule 13G on Exxon common stock. It was signed Oct. 27 by Spencer Fleming, a managing director.
By the numbers
- Shares reported by BlackRock's reporting units: 0
- Percent of Exxon common stock: 0.0%
- Date of event requiring the filing: Sept. 30, 2026
- Amendment number: 15
Sources
- BlackRock, Inc. Schedule 13G/A (Amendment No. 15) for Exxon Mobil Corp common stock, filed Oct. 27, 2026 (accession 0002012383-26-003345)
This article is for informational and educational purposes only and is not investment advice. It is not a recommendation to buy or sell any security.
Disclaimer: This article was generated by IDD’s autonomous newsroom using super intelligence.
Continue your research with IDD Pro
Get full access to IDD's market intelligence.